JP2023541179A5 - - Google Patents
Info
- Publication number
- JP2023541179A5 JP2023541179A5 JP2023516588A JP2023516588A JP2023541179A5 JP 2023541179 A5 JP2023541179 A5 JP 2023541179A5 JP 2023516588 A JP2023516588 A JP 2023516588A JP 2023516588 A JP2023516588 A JP 2023516588A JP 2023541179 A5 JP2023541179 A5 JP 2023541179A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- antibody
- containing seq
- isolated antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024035682A JP2024063234A (ja) | 2020-09-15 | 2024-03-08 | 新規な抗ａ２ａｐ抗体およびその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20196259.4 | 2020-09-15 | ||
| EP20196259 | 2020-09-15 | ||
| PCT/EP2021/075038 WO2022058261A2 (en) | 2020-09-15 | 2021-09-13 | Novel anti-a2ap antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024035682A Division JP2024063234A (ja) | 2020-09-15 | 2024-03-08 | 新規な抗ａ２ａｐ抗体およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541179A JP2023541179A (ja) | 2023-09-28 |
| JP2023541179A5 true JP2023541179A5 (https=) | 2023-10-10 |
| JP7454106B2 JP7454106B2 (ja) | 2024-03-21 |
Family
ID=72521424
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516588A Active JP7454106B2 (ja) | 2020-09-15 | 2021-09-13 | 新規な抗ａ２ａｐ抗体およびその使用 |
| JP2024035682A Pending JP2024063234A (ja) | 2020-09-15 | 2024-03-08 | 新規な抗ａ２ａｐ抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024035682A Pending JP2024063234A (ja) | 2020-09-15 | 2024-03-08 | 新規な抗ａ２ａｐ抗体およびその使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20240010750A1 (https=) |
| EP (1) | EP4214241A2 (https=) |
| JP (2) | JP7454106B2 (https=) |
| KR (1) | KR20230069171A (https=) |
| CN (1) | CN116249719A (https=) |
| AR (1) | AR123523A1 (https=) |
| AU (1) | AU2021343834A1 (https=) |
| CA (1) | CA3194792A1 (https=) |
| IL (1) | IL301307B2 (https=) |
| MX (1) | MX2023002984A (https=) |
| PE (1) | PE20240214A1 (https=) |
| TW (1) | TWI905264B (https=) |
| WO (1) | WO2022058261A2 (https=) |
| ZA (1) | ZA202405587B (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4214241A2 (en) * | 2020-09-15 | 2023-07-26 | Bayer Aktiengesellschaft | Novel anti-a2ap antibodies and uses thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| US5582862A (en) * | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| EP0571613B1 (en) | 1991-12-13 | 2003-09-17 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| GB9603256D0 (en) | 1996-02-16 | 1996-04-17 | Wellcome Found | Antibodies |
| US20030017147A1 (en) | 1996-09-20 | 2003-01-23 | Guy L Reed | Composition and method for enhancing fibrinolysis |
| GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| ES2244066T3 (es) | 1997-06-24 | 2005-12-01 | Genentech, Inc. | Procedimiento y composiciones de glicoproteinas galactosiladas. |
| AU759779B2 (en) | 1997-10-31 | 2003-05-01 | Genentech Inc. | Methods and compositions comprising glycoprotein glycoforms |
| DK1034298T3 (da) | 1997-12-05 | 2012-01-30 | Scripps Research Inst | Humanisering af murint antistof |
| DK1071700T3 (da) | 1998-04-20 | 2010-06-07 | Glycart Biotechnology Ag | Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet |
| NZ571596A (en) | 2001-08-03 | 2010-11-26 | Glycart Biotechnology Ag | Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| US7361740B2 (en) | 2002-10-15 | 2008-04-22 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| TWI335821B (en) | 2002-12-16 | 2011-01-11 | Genentech Inc | Immunoglobulin variants and uses thereof |
| US9296820B2 (en) | 2003-11-05 | 2016-03-29 | Roche Glycart Ag | Polynucleotides encoding anti-CD20 antigen binding molecules with increased Fc receptor binding affinity and effector function |
| EP1740615B1 (en) | 2004-03-31 | 2014-11-05 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| US20080226635A1 (en) | 2006-12-22 | 2008-09-18 | Hans Koll | Antibodies against insulin-like growth factor I receptor and uses thereof |
| CN101720368A (zh) | 2007-03-09 | 2010-06-02 | 中国抗体制药有限公司 | 储备多样性最大化的功能性人化抗体文库之构建及应用 |
| EP4214241A2 (en) * | 2020-09-15 | 2023-07-26 | Bayer Aktiengesellschaft | Novel anti-a2ap antibodies and uses thereof |
-
2021
- 2021-09-13 EP EP21773115.7A patent/EP4214241A2/en active Pending
- 2021-09-13 WO PCT/EP2021/075038 patent/WO2022058261A2/en not_active Ceased
- 2021-09-13 PE PE2023001168A patent/PE20240214A1/es unknown
- 2021-09-13 AU AU2021343834A patent/AU2021343834A1/en active Pending
- 2021-09-13 US US18/026,089 patent/US20240010750A1/en active Pending
- 2021-09-13 KR KR1020237012503A patent/KR20230069171A/ko active Pending
- 2021-09-13 MX MX2023002984A patent/MX2023002984A/es unknown
- 2021-09-13 IL IL301307A patent/IL301307B2/en unknown
- 2021-09-13 CN CN202180062581.XA patent/CN116249719A/zh active Pending
- 2021-09-13 JP JP2023516588A patent/JP7454106B2/ja active Active
- 2021-09-13 CA CA3194792A patent/CA3194792A1/en active Pending
- 2021-09-13 TW TW110133977A patent/TWI905264B/zh active
- 2021-09-15 AR ARP210102562A patent/AR123523A1/es unknown
-
2023
- 2023-06-06 US US18/329,700 patent/US20240034810A1/en active Pending
- 2023-11-30 US US18/525,736 patent/US12215168B2/en active Active
-
2024
- 2024-03-08 JP JP2024035682A patent/JP2024063234A/ja active Pending
- 2024-07-18 ZA ZA2024/05587A patent/ZA202405587B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2732032C2 (ru) | Антитела с двойной специфичностью | |
| US7767206B2 (en) | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto | |
| JP2024129090A5 (https=) | ||
| JP2021531254A5 (https=) | ||
| RU2682046C1 (ru) | Il-17a-связывающий агент и способы его применения | |
| US20200347130A1 (en) | CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof | |
| JP2019505527A5 (https=) | ||
| RU2017137010A (ru) | Анти-сеасам6 антитела и их применения | |
| CN112409488B (zh) | 针对多种冠状病毒的单克隆抗体及应用 | |
| RU2012112829A (ru) | Анти-gitr-антитела | |
| CA2754113A1 (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody | |
| RU2006122037A (ru) | Новые анти-il 13 антитела и их использование | |
| RU2018129874A (ru) | Антитела против фактора свертывания xi | |
| JP6358763B2 (ja) | インターロイキン−２０に対するヒト化抗体および炎症性疾患のための治療 | |
| US20190315886A1 (en) | Thrombin antibody, antigen-binding fragment and pharmaceutical use thereof | |
| JP2005535562A5 (https=) | ||
| KR20170052655A (ko) | 혈관내피 리파제의 효소 활성을 저해하는 인간화 모노클로널 항체 | |
| JP2023541179A5 (https=) | ||
| CN111094354B (zh) | 凝血酶抗体、其抗原结合片段及医药用途 | |
| JP2024512633A5 (https=) | ||
| JP7457880B2 (ja) | 新規なＮａｖ１．７モノクローナル抗体 | |
| JP2024505195A5 (https=) | ||
| JP2025503202A (ja) | 抗インターロイキン－１１抗体及びその使用 | |
| JP2023512320A5 (https=) | ||
| AU2016208453B2 (en) | Alpha-4-beta-7 heterodimer specific antagonist antibody |